Revamping Medical Regulations: A Call for Comprehensive Reform

By HEOR Staff Writer

November 16, 2023

The Regulatory Hurdle

Europe’s healthcare system, known for its extensive social security and fair healthcare access, faces a test of strength. Structural barriers in the existing regulatory framework hinder the prompt distribution of vital medical technologies. These technologies are crucial at every patient care stage.


The In Vitro Diagnostic Medical Devices Regulation (IVDR) and Medical Devices Regulation (MDR) were designed with the objective of creating a robust, transparent, predictable, and sustainable regulatory system for medical devices. The expectation was that these regulations would foster innovation while ensuring high levels of safety and health. However, more than half a decade into their implementation, the IVDR and MDR have fallen short of achieving these goals. The result is a sluggish, unpredictable, costly, and intricate process.

The Call for Medical Device Regulations Reform

MedTech Europe, a prominent representative of the medical technology industry, advocates for a comprehensive overhaul of the regulations to make them more beneficial for patients and European health systems. This reform should focus on three main areas: efficiency, innovation, and governance.

Efficiency: MedTech Europe suggests a more streamlined and cost-effective CE marking system. This system should enhance predictability, lessen administrative burdens, and be adaptable to external changes.

Innovation: The implementation of an innovation principle is advised. This would expedite the integration of the latest medical technologies into European healthcare systems, through the use of specific assessment pathways and early dialogues with developers.

Governance: The creation of a singular, dedicated structure to supervise and manage the regulatory system is recommended. This structure should have the power to make decisions at the system level.

Conclusion

To ensure that Europe maintains its high standards of care, and continues to leverage innovative medical technology, it is crucial to reform the existing regulatory framework. The solutions proposed by MedTech Europe provide a starting point for discussions among all stakeholders, with the aim of addressing the current challenges and reshaping the future of Europe’s healthcare system.

Reference url

Recent Posts

Closing the East-West Divide: Addressing Healthcare Investment Disparities in Central and Eastern...

By João L. Carapinha

April 14, 2026

A recent study commissioned by EFPIA and authored by leading CEE academics—Dr. Slaveyko Djambazov, Dr. Luka Voncina, Dr. Aleš Rod, and Dr. Marcin Czech—reveals that despite accelerated public health spending growth in several CEE countries, structural underinvestment persists. This produces marke...
Utah’s AI Medication Prescribing Risks: Navigating the Challenges of Autonomous Systems
In this update we examine how Utah’s groundbreaking partnership with an AI company has introduced serious AI medication prescribing risks by authorizing unsupervised prescribing of nearly 200 medications. In January 2026, Utah partnered with Doctronic to deploy the first system in the United S...
Safeguarding Access: Navigating Pharmaceutical Cost Pressures in Portugal

By João L. Carapinha

April 13, 2026

Pharmaceutical cost pressures are mounting in Portugal, with industry leaders warning that price increases for certain medicines appear inevitable in the medium term despite the government’s commitment to strict controls in the 2026 annual review. Global Cost Drivers Threaten Generic...